aspartate-beta-hydroxamate has been researched along with Inflammation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Jiang, H; Lian, M; Liu, Y; Shan, G; Wu, M; Wu, S; Xu, Y; Zhang, H | 1 |
1 other study(ies) available for aspartate-beta-hydroxamate and Inflammation
| Article | Year |
|---|---|
Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Asparagine; Cells, Cultured; Choroid; Choroidal Neovascularization; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Inflammation; Injections, Intravenous; Intravitreal Injections; Mice; Mice, Inbred C57BL; Retinal Pigment Epithelium; Vascular Endothelial Growth Factor A; Visual Acuity | 2019 |